Genedrive Plc (GDR)Genedrive Plc develops point-of-care molecular diagnostics technology used for rapid testing in healthcare settings.
Ondine Biomedical, Inc. (OBI)Ondine Biomedical, Inc. develops antimicrobial photodisinfection technology aimed at reducing hospital-acquired infections.
Provexis PLC (LSE:PXS) gained4.10%as investors showed renewed interest in healthcare and nutraceutical companies focused on preventive wellness solutions. Rising consumer awareness of heart health, functional nutrition and scientifically validated dietary ingredients supported buying activity. Positive sentiment toward health-focused businesses and defensive healthcare stocks also …
LSE:FUMis a pharmaceutical company focused on developing and commercialising innovative topical treatments. Its lead product, Eroxon®, is an over-the-counter topical gel for the treatment of erectile dysfunction (ED), which has received regulatory approvals in several key international markets.
Proteome Sciences plc (LSE:PRM) surged26.47%as investors showed strong interest in biotechnology companies operating in precision medicine and proteomics. Growing optimism surrounding life sciences innovation, increasing demand for biomarker research and improved sentiment across healthcare technology companies supported significant buying activity. The sharp upward move …
Poolbeg Pharma PLC gained7.14%during today's trading session, making it one of the stronger-performing AIM-listed biotechnology stocks. The share-price rise appears to reflect improving investor sentiment toward life sciences companies, growing interest in artificial intelligence-driven drug development and optimism surrounding the company's expanding pharmaceutical pipeline.
Oxford Nanopore Technologies became one of the most actively discussed UK healthcare stocks after issuing a disappointing first-half trading update. While revenue continued to grow year-over-year, management admitted that performance fell below internal expectations, triggering a sharp sell-off in the shares.
• AOTI shares gained 4.00% on 13 July 2026, closing at 65.00 GBX.• AOTI, Inc. has a market capitalization of approximately 66.47 million GBP, placing it in the small-cap segment.• The company develops advanced wound care therapies and medical technologies for the treatment of …
• RENX shares declined 7.14% on 13 July 2026, closing at 2.60 GBX.• Renalytix Plc has a market capitalization of approximately 12.24 million GBP, placing it in the micro-cap segment.• The company develops kidney disease diagnostics solutions using advanced data analytics and artificial intelligence …
• CHLL shares gained 9.09% on 13 July 2026, closing at 2.40 GBX.• Chill Brands Group PLC has a market capitalization of approximately 1.15 million GBP, placing it in the micro-cap segment.• The company focuses on consumer wellness products and emerging healthcare-related markets.• Product …